Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

BACKGROUND: With a decline in malaria burden, innovative interventions and tools are required to reduce malaria transmission further. Mass drug administration (MDA) of artemisinin-based combination therapy (ACT) has been identified as a potential tool to further reduce malaria transmission, where co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabira, Edgard Diniba, Soumare, Harouna M, Lindsay, Steven W, Conteh, Bakary, Ceesay, Fatima, Bradley, John, Kositz, Christian, Broekhuizen, Henk, Kandeh, Balla, Fehr, Alexandra E, Nieto-Sanchez, Claudia, Ribera, Joan Muela, Peeters Grietens, Koen, Smit, Menno Roderick, Drakeley, Chris, Bousema, Teun, Achan, Jane, D’Alessandro, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714640/
https://www.ncbi.nlm.nih.gov/pubmed/33211022
http://dx.doi.org/10.2196/20904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714640/
https://www.ncbi.nlm.nih.gov/pubmed/33211022
http://dx.doi.org/10.2196/20904

Ejemplares similares